RETRACTED: Ahmed et al. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. Nanomaterials 2020, 10, 1270

Nanomaterials (Basel). 2024 Jan 12;14(2):174. doi: 10.3390/nano14020174.

Osama A A Ahmed^{1

2}, Usama A Fahmy¹, Shaimaa M Badr-Eldin^{1

3}, Hibah M Aldawsari¹, Zuhier A Awan⁴, Hani Z Asfour⁵, Ahmed K Kammoun⁶, Giuseppe Caruso⁷, Filippo Caraci^{7

8}, Anas Alfarsi¹, Raniyah A Al-Ghamdi⁹, Rawan A Al-Ghamdi¹⁰, Nabil A Alhakamy^{1

2

11}

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
² Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
³ Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
⁴ Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁵ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁶ Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
⁷ Oasi Research Institute-IRCCS, Via Conte Ruggero, 73, 94018 Troina (EN), Italy.
⁸ Department of Drug Sciences, University of Catania, 95125 Catania, Italy.
⁹ Ibn Sina National College for Medical Studies, Clinical Pharmacy Department, Jeddah 22421, Saudi Arabia.
¹⁰ Ibn Sina National College for Medical Studies, Jeddah 22421, Saudi Arabia.
¹¹ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Abstract

The Journal retracts the article "Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route" [...].